Organic Spices, Inc. Recalls Spicely Organic Sumac Due to Mislabeled Salt Content

Source: FDA · CA, CO, IL, IN, MI, NC, NY, OH, OR, PA, TX, UT, WA

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Organic Spices, Inc. has issued a voluntary recall for Spicely Organic Sumac because the product contains salt despite packaging claims stating it is salt-free.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on April 6, 2026 and geographically references CA, CO, IL, IN, MI, NC, NY, OH, OR, PA, TX, UT, WA. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, food.

What Happened

Organic Spices, Inc. of Fremont, California, has initiated a voluntary recall of its Spicely Organic Sumac. The recall was issued after it was discovered that the product contains salt and is mislabeled. While the front of the packaging states "NO SALT," the ingredients list correctly identifies salt as an ingredient, creating a labeling contradiction that could mislead consumers.

Which Products Are Affected

The recall involves approximately 980 cases, totaling 11,760 jars, of the following product:

  • Product Name: spicely ORGANIC sumac
  • Size: 2oz (56g) jars
  • UPC: 826998007339
  • Lot Number: 103656B
  • Best By Dates: 07/01/2031 and 07/02/2031

The affected products were distributed to retailers in the following states: California, Colorado, Illinois, Indiana, Michigan, North Carolina, New York, Ohio, Oregon, Pennsylvania, Texas, Utah, and Washington.

What You Should Do

Consumers who purchased the affected Spicely Organic Sumac and are monitoring their salt intake should discontinue use of the product. For further information or to inquire about returns, consumers may contact Organic Spices, Inc., located at 4180 Business Center Dr, Fremont, CA 94538.

Why This Matters

This recall is classified as Class II by the FDA, indicating that the product may cause temporary or medically reversible adverse health consequences. This is particularly significant for individuals on sodium-restricted diets who rely on accurate labeling to manage health conditions such as hypertension or kidney disease.

Source

Information provided by the FDA. Recall Number: H-0465-2026.

Original source: FDA Official Notice ↗

All FDA Recalls →

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Organic Spices, Inc. has issued a voluntary recall for Spicely Organic Sumac because the product contains salt despite packaging claims stating it is salt-free.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects CA, CO, IL, IN, MI, NC, NY, OH, OR, PA, TX, UT, WA. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.